Get the Stockscreener App
0.50
0.48%
-0.0024
Xortx Therapeutics Inc stock is traded at $0.50, with a volume of 56,527.
It is down -0.48% in the last 24 hours and down -12.28% over the past month.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.5024
Open:
$0.51
24h Volume:
56,527
Relative Volume:
0.86
Market Cap:
$3.48M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-50.00
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
-2.93%
1M Performance:
-12.28%
6M Performance:
-32.80%
1Y Performance:
-45.05%
1-Day Range:
$0.50
$0.5297
1-Week Range:
$0.464
$0.579
52-Week Range:
$0.464
$1.41
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.50 | 3.50M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.43 | 118.13B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.89 | 79.79B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
845.79 | 52.71B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
351.12 | 46.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
348.49 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
Investor Mood: Why is OSBC stock going upRate Cut & Real-Time Price Movement Reports - baoquankhu1.vn
Travel Stocks: Whats the RSI of XORTX Therapeutics Inc stock2025 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
EPS Watch: Can XORTX Therapeutics Inc continue delivering strong returns - baoquankhu1.vn
Is XORTX Therapeutics Inc. a speculative investment2025 Market WrapUp & Weekly Consistent Profit Watchlists - Mfd.ru
Does XORTX Therapeutics Inc. meet Warren Buffett’s criteriaWeekly Trend Report & Short-Term Trading Opportunity Alerts - Mfd.ru
Earnings Miss: What is the target price for XORTX Therapeutics Inc stockInflation Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Treasury Yields: Does XORTX Therapeutics Inc meet Warren Buffetts criteriaJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Market Fear: What is XORTX Therapeutics Incs TAM Total Addressable MarketJuly 2025 Momentum & AI Optimized Trade Strategies - baoquankhu1.vn
XORTX leans into genetic breakthroughs in gout as it reshapes board and advances oxypurinol - MSN
Dividend Watch: Is XORTX Therapeutics Inc vulnerable to short sellers2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Sentiment Recap: How XORTX Therapeutics Inc stock performs after earningsWeekly Trade Review & Reliable Momentum Entry Alerts - Bộ Nội Vụ
Is XORTX Therapeutics Inc. stock positioned well for digital economyOil Prices & Weekly Setup with ROI Potential - Улправда
Revenue per share of XORTX Therapeutics Inc. – NASDAQ:XRTX - TradingView — Track All Markets
Why XORTX Therapeutics Inc. stock remains resilientJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
Is XORTX Therapeutics Inc. (ANUA) stock a buy before earnings resultsQuarterly Trade Review & Weekly Top Stock Performers List - ulpravda.ru
Will XORTX Therapeutics Inc. stock attract more institutional investors2025 Risk Factors & Long Hold Capital Preservation Tips - ulpravda.ru
Contact | Statesman-ExaminerXORTX Therapeutics Inc.Common Stock (Nasdaq:XRTX) Stock Quote - FinancialContent
XORTX Therapeutics : Investor Presentation - MarketScreener
Will XORTX Therapeutics Inc. stock beat EPS estimatesStock Split Announcements & High Profit Portfolio Growth - Улправда
Published on: 2026-01-07 21:30:14 - Улправда
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing - MSN
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol - TipRanks
Huge gout genetics study highlights target in kidney disease research - Stock Titan
XORTX Announces USD $3 Million Offering - 富途牛牛
Multi Factor Analysis Ranks Jaihind Synthetics Limited as Strong BuyInsider Selling Patterns & Lower Drawdowns With Smart Position Sizing - bollywoodhelpline.com
Order Book Volume Tilts Bullish on Adani Wilmar LimitedCurrency Fluctuation Impact & Breakout Stock Alerts - bollywoodhelpline.com
Chart Analysts Warn of Resistance Near Glance Finance Limited PriceCapital Gains Strategies & Small Capital Trading Plans - bollywoodhelpline.com
Fibonacci Levels Suggest Recovery for Johnson Pharmacare LimitedMomentum Trading Signals & Analysts Are Raving About These Shares - bollywoodhelpline.com
Global Longlife Hospital and Research Limited (543520) Sees Unusual Trading VolumeFinancial Sector Performance & Small Entry Cost Trading - bollywoodhelpline.com
Can Fabino Life Sciences Limited Bounce Back From Weekly LowEx-Dividend Date Alerts & Outstanding Investment Returns - bollywoodhelpline.com
What drives XORTX Therapeutics Inc stock priceEconomic Data Impact & Free Stock Market Mentorship Programs - earlytimes.in
Aug Decliners: Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Fast Gaining Stock Reports - ulpravda.ru
How XORTX Therapeutics Inc. stock reacts to inflationary pressures2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - Улправда
Why XORTX Therapeutics Inc. (ANUA) stock could be top winnerJuly 2025 Snapshot & Verified Entry Point Signals - Улправда
Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Pullbacks & Real-Time Market Sentiment Reports - Улправда
Growth Value: Is XORTX Therapeutics Inc. stock positioned well for digital economyJuly 2025 Snapshot & Low Drawdown Trading Techniques - Улправда
Will XORTX Therapeutics Inc. stock attract ESG investorsCEO Change & Daily Technical Forecast Reports - Улправда
What technical charts say about XORTX Therapeutics Inc. stockStock Surge & Accurate Intraday Trading Signals - Улправда
Certain Stock Options of XORTX Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Aug Analyst Calls: Will XORTX Therapeutics Inc stock attract ESG investorsJuly 2025 Chart Watch & Growth Focused Stock Reports - BỘ NỘI VỤ
XORTX Therapeutics Announces US$1.1 Million Direct Offering - MSN
XORTX Therapeutics (XRTX) Stock Analysis Report | Financials & Insights - Benzinga
Can XORTX Therapeutics Inc. (ANUA) stock deliver strong annual returnsMarket Risk Analysis & Safe Entry Zone Tips - Newser
Is XORTX Therapeutics Inc. stock a defensive play in 2025Weekly Earnings Recap & Stepwise Swing Trade Plans - Newser
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
4.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):